Fulvestrant Injection 250 MG / 5 ML [FULVESER]
FULVESER is indicated for the treatment of hormone receptor positive Metastatic Breast Cancer in postmenopausal women with disease progression following antiestrogen therapy.
Global Medical Directory is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.